Nautilus Biotechnology, Inc. (NAUT) Financials

NAUT Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 177.8 million 33.4 million
Dec. 31, 2025 191.1 million 34.1 million
Sept. 30, 2025 200.9 million 31.8 million
June 30, 2025 213.2 million 32.1 million

NAUT Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -13.6 million 1.4 million
Dec. 31, 2025 -12.6 million 1.5 million
Sept. 30, 2025 -11.5 million 1.5 million
June 30, 2025 -13.7 million 1.7 million

NAUT Net Income
Graph available only for paid members. Upgrade to see it.
DateNet Income
March 31, 2026 -14.7 million
Dec. 31, 2025 -13.8 million
Sept. 30, 2025 -13.6 million
June 30, 2025 -15.0 million

NAUT Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 95.9 million 25.0 million 28.9 million
Dec. 31, 2025 103.4 million 26.2 million 30.0 million
Sept. 30, 2025 131.4 million - 22.8 million
June 30, 2025 147.9 million - 28.2 million

NAUT Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 126.6 million
Dec. 31, 2025 126.3 million
Sept. 30, 2025 126.3 million
June 30, 2025 126.2 million

NAUT Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 510000 9.4 million 5.3 million -
Dec. 31, 2025 244000 10.9 million 5.8 million -
Sept. 30, 2025 418000 9.6 million 5.9 million -
June 30, 2025 396000 10.4 million 6.7 million -

NAUT Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 - 1.5 million
Dec. 31, 2025 - 1.6 million
Sept. 30, 2025 - 1.6 million
June 30, 2025 - 1.6 million

NAUT

Price: $2.17

52 week price:
0.62
4.31

Earnings Per Share: -0.46 USD

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 189600

Market Capitalization: 322.1 million

Links: